American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$374M |
| 2 |
Meta Platforms (Facebook)
META
|
+$255M |
| 3 |
Salesforce
CRM
|
+$200M |
| 4 |
Target
TGT
|
+$132M |
| 5 |
Reinsurance Group of America
RGA
|
+$124M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$322M |
| 2 |
Visa
V
|
+$240M |
| 3 |
T-Mobile US
TMUS
|
+$229M |
| 4 |
MSCI
MSCI
|
+$209M |
| 5 |
IQVIA
IQV
|
+$209M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.34% |
| 2 | Healthcare | 13.84% |
| 3 | Financials | 13.35% |
| 4 | Consumer Discretionary | 11.5% |
| 5 | Industrials | 10.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Seer Inc
SEER
$116M
| $111K | ﹤0.01% |
26,066
+10,999
| +73% | +$43K |
|
2602
Medallion Financial
MFIN
$262M
| $111K | ﹤0.01% |
13,982
| – | – |
|
2603
Clarus
CLAR
$144M
| $110K | ﹤0.01% |
+12,060
| New | +$106K |
|
2604
Vuzix
VUZI
$217M
| $109K | ﹤0.01% |
+21,461
| New | +$95K |
|
2605
Five Point Holdings
FPH
$372M
| $108K | ﹤0.01% |
37,448
-492
| -1% | -$1.18K |
|
2606
BioCryst Pharmaceuticals
BCRX
$2.52B
| $105K | ﹤0.01% |
14,899
-51
| -0.3% | -$409 |
|
2607
Broadwind
BWEN
$128M
| $102K | ﹤0.01% |
+26,639
| New | +$111K |
|
2608
Kodiak Sciences
KOD
$2.68B
| $101K | ﹤0.01% |
+14,641
| New | +$89.5K |
|
2609
Fate Therapeutics
FATE
$310M
| $101K | ﹤0.01% |
+21,214
| New | +$117K |
|
|
VISN
2610
Vistance Networks Inc
VISN
$2.72B
| $101K | ﹤0.01% |
17,888
-43,296
| -71% | -$207K |
|
|
BLUE
2611
DELISTED
bluebird bio
BLUE
| $100K | ﹤0.01% |
1,526
+786
| +106% | +$57.5K |
|
2612
Frontier Group Holdings
ULCC
$1.6B
| $99K | ﹤0.01% |
+10,241
| New | +$92K |
|
2613
eHealth
EHTH
$39.4M
| $98.2K | ﹤0.01% |
+12,211
| New | +$97.6K |
|
|
GBIO
2614
DELISTED
Generation Bio
GBIO
| $97.8K | ﹤0.01% |
1,779
+734
| +70% | +$33.7K |
|
2615
Geron
GERN
$1B
| $96.8K | ﹤0.01% |
+30,164
| New | +$85.8K |
|
2616
Ribbon Communications
RBBN
$379M
| $94.9K | ﹤0.01% |
34,009
+20,505
| +152% | +$56.9K |
|
2617
El Pollo Loco
LOCO
$467M
| $93.8K | ﹤0.01% |
+10,697
| New | +$100K |
|
2618
Fulcrum Therapeutics
FULC
$281M
| $93.8K | ﹤0.01% |
28,417
+8,214
| +41% | +$24.1K |
|
2619
Culp Inc
CULP
$43.9M
| $92.9K | ﹤0.01% |
18,699
| – | – |
|
2620
Lands' End
LE
$390M
| $92.8K | ﹤0.01% |
11,954
+1,413
| +13% | +$11.4K |
|
2621
MannKind Corp
MNKD
$1.19B
| $92K | ﹤0.01% |
22,609
-354
| -2% | -$1.48K |
|
2622
Olema Pharmaceuticals
OLMA
$913M
| $91.6K | ﹤0.01% |
+10,142
| New | +$61.2K |
|
2623
SelectQuote
SLQT
$130M
| $90.4K | ﹤0.01% |
+46,337
| New | +$78K |
|
|
YMAB
2624
DELISTED
Y-mAbs Therapeutics
YMAB
| $89.4K | ﹤0.01% |
+13,173
| New | +$98.7K |
|
2625
Nuvation Bio
NUVB
$2.21B
| $89.2K | ﹤0.01% |
49,569
+22,073
| +80% | +$37.5K |
|
Similar funds
American Century Companies's Q2 2023 Portfolio in Review
As of Q2 2023, American Century Companies held 2,884 positions worth $133B, up 4.5% from $127B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
American Century Companies's Q2 2023 filing shows 216 new, 1,601 increased, 807 reduced and 96 closed positions. Its largest new stake was Kenvue: 2,518,495 shares worth $66.5M. The largest sale was Microsoft, an estimated $322M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- American Century Companies's largest Q2 2023 buy was Kenvue: 2,518,495 shares worth $66.5M.
- American Century Companies added most to Becton Dickinson in Q2 2023, an estimated $374M increase.
- American Century Companies's biggest Q2 2023 reduction was Microsoft, cutting an estimated $322M.
- American Century Companies fully exited Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6.00% Mandatory Convertible Preferred Stock, Series B in Q2 2023, selling an estimated $199M.
- American Century Companies's ten largest holdings make up 22% of its $133B portfolio in Q2 2023.
- American Century Companies opened 216 new positions and closed 96 in Q2 2023.
- American Century Companies's portfolio value rose 4.5% quarter-over-quarter to $133B.
Based on American Century Companies's 13F filing for Q2 2023, filed 14 Aug 2023.